A detailed history of Neos Investment Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Neos Investment Management LLC holds 18,508 shares of VKTX stock, worth $783,258. This represents 0.04% of its overall portfolio holdings.

Number of Shares
18,508
Previous 17,083 8.34%
Holding current value
$783,258
Previous $906 Million 29.39%
% of portfolio
0.04%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$49.84 - $70.47 $71,022 - $100,419
1,425 Added 8.34%
18,508 $1.17 Billion
Q2 2024

Aug 14, 2024

BUY
$47.39 - $80.2 $107,622 - $182,134
2,271 Added 15.33%
17,083 $906 Million
Q1 2024

May 13, 2024

BUY
$17.4 - $94.5 $4,193 - $22,774
241 Added 1.65%
14,812 $1.21 Billion
Q4 2023

Feb 13, 2024

BUY
$9.24 - $19.64 $134,636 - $286,174
14,571 New
14,571 $271 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.25B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Neos Investment Management LLC Portfolio

Follow Neos Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neos Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neos Investment Management LLC with notifications on news.